|
2025
|
Invention
|
Tale protein scaffolds involving fusions of monopartite and bipartite nls. The present invention ... |
|
|
Invention
|
Targeted gene insertion for improved immune cells therapy.
The invention pertains to the field o... |
|
|
Invention
|
Method for improving production of car t cells.
A method for engineering less alloreactive immun... |
|
|
Invention
|
Method for generating t-cells compatible for allogenic transplantation.
The present invention pe... |
|
|
Invention
|
Compositions and methods for hbb-editing in hspc. The present invention generally relates to the ... |
|
|
Invention
|
Homogenization device. The invention presents a device for homogenization and agitation of conten... |
|
2024
|
Invention
|
Cellular immunotherapy for repetitive administration.
The present invention provides composition... |
|
|
Invention
|
Universal anti-cd22 chimeric antigen receptor engineered immune cells.
The present invention rel... |
|
|
Invention
|
Engineering wheat with increased dietary fiber.
Materials and methods are provided for making pl... |
|
|
Invention
|
Methods for non-transgenic genome editing in plants.
Materials and methods for creating genome-e... |
|
|
Invention
|
Methods for identifying tale base editors off-sites. The present invention relates to methods usi... |
|
|
Invention
|
Modular electroporation method and system. A device is provided for delivering electrical signals... |
|
|
Invention
|
Inhibitory chimeric antigen receptors.
The invention relates to an inhibitory chimeric antigen r... |
|
|
Invention
|
Electroporation device and method. A device is provided for filling and emptying of an electropor... |
|
2023
|
Invention
|
Universal anti-cd22 chimeric antigen receptor engineered immune cells. The present invention rela... |
|
|
Invention
|
Targeted gene insertion for improved immune cells therapy. The invention pertains to the field of... |
|
|
Invention
|
Two-dose regimen in immunotherapy. This document relates to methods of immunotherapy comprising a... |
|
|
Invention
|
Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy.
Met... |
|
|
Invention
|
Enhancing efficacy and safety of t-cell-mediated immunotherapy. This document relates to engineer... |
|
|
Invention
|
Cd33 specific chimeric antigen receptors for cancer immunotherapy.
The present invention relates... |
|
|
Invention
|
Mab-driven chimeric antigen receptor systems for sorting/depleting engineered immune cells.
A po... |
|
|
Invention
|
Method for generating t-cells compatible for allogenic transplantation. The present invention per... |
|
|
Invention
|
Processes for generating til products using pd-1/tigit talen double knockdown.
The present inven... |
|
|
Invention
|
Processes for generating til products using pd-1/tigit talen double knockdown. The present invent... |
|
|
Invention
|
Cd19 specific chimeric antigen receptor and uses thereof.
The present invention relates to chime... |
|
|
Invention
|
Enhancing safety of t-cell-mediated immunotherapy.
This document relates to engineered immune ce... |
|
|
Invention
|
Enhancing safety of t-cell-mediated immunotherapy. This document relates to engineered immune cel... |
|
|
Invention
|
Tale base editors for gene and cell therapy.
The present invention relates to methods using base... |
|
|
Invention
|
Tale base editors for gene and cell therapy. The present invention relates to methods using base ... |
|
|
Invention
|
Cells for immunotherapy engineered for targeting antigen present both on immune cells and patholo... |
|
|
Invention
|
Gene therapy for the treatment of activated pi3kinase delta syndrome type 1 (apds1).
The present... |
|
|
Invention
|
Gene therapy for the treatment of activated pi3kinase delta syndrome type 1 (apds1). The present ... |
|
|
Invention
|
Sequential gene editing in primary immune cells.
The invention pertains to the field of adaptive... |
|
|
Invention
|
Canola with high oleic acid.
Materials and methods for creating canola (e.g., Brassica napus) li... |
|
2022
|
Invention
|
New tale protein scaffolds with improved on-target/off-target activity ratios. The present invent... |
|
|
Invention
|
Methods for engineering allogeneic and highly active t cell for immunotheraphy.
The present inve... |
|
|
Invention
|
Enhancing efficacy of t-cell-mediated immunotherapy by modulating cancer-associated fibroblasts i... |
|
|
Invention
|
Gene therapy for the treatment of severe combined immunodeficiency (scid) related to rag1.
The p... |
|
|
Invention
|
Gene therapy for the treatment of hyper-ige syndrome (hies) by targeted gene integration.
The pr... |
|
|
Invention
|
New anti-muc1 cars and gene edited immune cells for solid tumors cancer immunotherapy.
The prese... |
|
|
Invention
|
Cish gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy.
The prese... |
|
2021
|
Invention
|
Use of aminoquinoline compounds for higher gene integration.
The invention provides aminoquinoli... |
|
|
Invention
|
Dual car-t cells.
The present invention concerns new engineered immune cells expressing two CARs... |
|
|
Invention
|
T-cells expressing immune cell engagers in allogenic settings.
The invention relates to therapeu... |
|
|
Invention
|
Method for determining potency of chimeric antigen receptor expressing immune cells.
The inventi... |
|
|
Invention
|
Methods to genetically modify cells for delivery of therapeutic proteins. The present disclosure ... |
|
|
Invention
|
Methods for targeted insertion of exogenous sequences in cellular genomes.
The present disclosur... |
|
|
P/S
|
Chemicals and biochemical products for industrial and
scientific use for transferring biological... |
|
|
P/S
|
Chemicals and biochemical products for industrial and scientific use and not for medical or veter... |
|
|
P/S
|
Scientific, research, and production electronic apparatus and electronic instruments for the deve... |
|
|
P/S
|
Scientific, research, or production apparatus and
instruments for pharmaceuticals; electric and ... |
|
2019
|
Invention
|
Combination comprising allogeneic immune cells deficient for an antigen present on both t-cells a... |
|
2018
|
P/S
|
Pharmaceutical, veterinary and hygienic products, foods,
beverages and dietary substances for me... |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer, immune system related diseases and disorders... |
|
2017
|
Invention
|
Tal- effector nuclease (talen) -modified allogenic cells suitable for therapy.
The invention rel... |
|
|
P/S
|
Pharmaceuticals, veterinary and sanitary preparations, dietetic food, beverages and substances ad... |
|
2013
|
P/S
|
Biological preparations for medical or therapeutic,
pharmaceutical and/or veterinary use, chemic... |
|
2011
|
P/S
|
Chemical, biochemical, biotechnological and bacteriological products for use in industry, agricul... |
|
|
P/S
|
Chemical, biochemical, biotechnological and bacteriological
products for use in industry, scienc... |
|
2009
|
P/S
|
Chemical, biochemical, biotechnological and bacteriological
products used in industry, science, ... |
|
2001
|
P/S
|
Chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture... |
|
2000
|
P/S
|
Chemical, biochemical, biotechnological and bacteriological preparations used in industry and sci... |
|
|
P/S
|
Chemical, biochemical, biotechnological and bacteriological preparations used in industry, scienc... |
|
|
P/S
|
Chemical, biochemical, biotechnological and bacteriological
products for industrial, scientific,... |
